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The Listeria monocytogenes lemA Gene Product Is Not Required for
Intracellular Infection or To Activate fMIGWII-Specific T Cells
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Clearance of the intracellular bacterial pathogen Listeria monocytogenes requires antigen-specific CD8 T
cells. Recently it was shown that activation of class Ib major histocompatibility complex (MHC)-restricted
CD8 T cells alone is sufficient for immune protection against listeriae. A major component of the class Ib
MHC-restricted T-cell response is T cells that recognize formylated peptide antigens presented by M3 mole-
cules. Although three N-formylated peptides derived from L. monocytogenes are known to bind to M3 molecules,
fMIGWII is the immunodominant epitope presented by M3 during infection of mice. The source of fMIGWII
peptide is the L. monocytogenes lemA gene, which encodes a 30-kDa protein of unknown function. In this report,
we describe the generation of two L. monocytogenes lemA deletion mutants. We show that lemA is not required
for growth of listeriae in tissue culture cells or for virulence during infection of mice. Surprisingly, we found
that fMIGWII-specific T cells were still primed following infection with lemA mutant listeriae, suggesting that
L. monocytogenes contains at least one additional antigen that is cross-reactive with the fMIGWII epitope. This
cross-reactive antigen appears to be a small protease-resistant molecule that is secreted by L. monocytogenes.
Listeria monocytogenes is a gram-positive bacterium that
causes food-borne illness, primarily in pregnant women and
neonates. L. monocytogenes has also been used for decades as
a model organism to better understand the interactions of host
cells with intracellular bacterial pathogens. The mouse model
of listeriosis has been used extensively to characterize the im-
mune response to intracellular infection, in particular the role
of CD8 T cells.
Components of innate immunity are primarily responsible
for clearing sublethal doses of bacteria from the host during
primary L. monocytogenes infection of mice (4, 14, 23). How-
ever, antigen-specific memory CD8 T cells are stimulated
during this initial infection that can protect mice from second-
ary challenges with doses of Listeria that would otherwise be
lethal. Listeria-specific protective immune responses are not
generated in mice that lack CD8 T cells (9, 17). The central
role of CD8 T cells has been the impetus for many studies
directed at identifying which Listeria antigens are recognized
by CD8 T cells and which class I major histocompatibility
complex (MHC) molecules present these antigens during the
course of L. monocytogenes infection.
The class Ia MHC-restricted T-cell response to Listeria has
been well characterized, and several Kd-restricted epitopes
derived from L. monocytogenes have been identified. However,
it was recently discovered that mice lacking class Ia MHC
molecules also have the capacity to clear L. monocytogenes
infection, suggesting that class Ib MHC-restricted CD8 T
cells are sufficient for the generation of a protective immune
response against Listeria (5, 19). A large part of the class Ib
MHC response may be M3 restricted, as suggested by a recent
study that used M3-specific antibodies to block antigen pre-
sentation to CD8 T cells (20).
M3 is a nonclassical MHC protein that displays minimal
polymorphism within laboratory strains of mice. It is expressed
on a wide variety of cell types at a much lower level than class
Ia MHC molecules (21). M3 preferentially binds short, hydro-
phobic peptides with a formylmethionine (fM) at the N termi-
nus. In eukaryotic cells, the only source of formylated peptides
is one of 13 mitochondrial proteins. The paucity of epitopes
that are able to bind to M3 results in retention of M3 mole-
cules within the Golgi network (3). In contrast, all prokaryotic
protein synthesis is initiated with N-formylmethionine, and
therefore it has been postulated that M3 molecules have
evolved specifically to present bacterial peptide antigens. In
fact, the cell surface level of M3 increases significantly upon
infection with L. monocytogenes, presumably due to the greatly
increased number of formylated peptides available within the
cell (3).
During L. monocytogenes infection, M3-restricted CD8 T
cells that recognize at least three formylated peptides thought
to be derived from Listeria are activated: fMIVIL, fMIGWII,
and fMIVTLF (13, 16). The magnitude of Listeria-specific M3-
restricted T-cell responses seems to vary considerably from
mouse to mouse even with genetically identical mice, but
fMIGWII is always the immunodominant epitope presented by
M3 molecules during Listeria infection (6, 20). Adoptive trans-
fer of an fMIGWII-specific T-cell clone into naïve mice re-
sulted in some degree of protection against subsequent chal-
lenge with L. monocytogenes (18).
Lenz et al. screened a library of Escherichia coli expressing
L. monocytogenes genome fragments to identify the product of
the L. monocytogenes lemA (Listeria epitope with M3) gene as
the source of fMIGWII peptide (10). lemA encodes a 30-kDa
protein of unknown function with no significant homology to
any known protein in currently available databases. The lemA
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gene may be transcribed as part of an operon containing lemA
and the gene located immediately downstream, which codes
for a 33-kDa protein with homology to heat shock proteins and
has been termed lemB (10). The N terminus of LemA is pre-
dicted to orient outside the bacterium, which may explain how
the N-formyl group avoids bacterial cytosolic formylases and is
retained on the peptide.
We generated lemA mutant strains of L. monocytogenes in
order to determine whether an fMIGWII-specific T-cell re-
sponse is a required component of class Ib MHC-restricted CD8
T-cell-mediated immunity against Listeria. In this report, we pro-
vide evidence that lemA is not essential for the metabolism or
virulence of L. monocytogenes and that, more surprisingly, it is
also not required for the priming of fMIGWII-specific CD8 T
cells in mice. These findings led to the characterization of a small,
protease-resistant antigen in L. monocytogenes that appears to be
cross-reactive with the fMIGWII epitope.
MATERIALS AND METHODS
Bacteria. L. monocytogenes 10403s was used as the parental strain for all
mutations generated in this study. The reference strain DP-L3903, an erythro-
mycin-resistant derivative of 10403s (1), was generously provided by Dan Portnoy
(Berkeley). Listeria strains were grown at 30°C without agitation in brain heart
infusion (BHI) medium (Difco) supplemented with 2 g of erythromycin per ml
where indicated. For infection of mice, frozen culture stocks were thawed, grown
with agitation at 37°C to early log phase in BHI broth, and diluted in phosphate-
buffered saline (PBS) prior to injection. L. monocytogenes 10403s has a 50%
lethal dose (LD50) of 104 CFU in BALB/c mice.
Construction of lemA mutant strains of L. monocytogenes. Mutagenesis by
overlap extension PCR was used to construct L. monocytogenes strain SD9-1, in
which codons 2 to 16 of lemA (including the fMIGWII epitope) were deleted and
replaced with a SacI restriction site (see Fig. 1B). Briefly, a fragment spanning
the region 1,038 bp upstream of lemA to the ATG start codon of lemA was
amplified from L. monocytogenes 10403s genomic DNA with primers that added
a 5 BamHI site and a 3 SacI site. The primer sequences used were 5-AGAG
GATCCTGGTATTGACGCAGTAATCGTTTC-3 and 5-GGGGAGCTCCA
TAATTAATCTCCTCCT-3. After restriction digestion, the fragment was sub-
cloned into the temperature-sensitive suicide vector pKSV7 (22), resulting in
plasmid pONT2.
A second fragment spanning bp 49 of lemA to a region 855 bp downstream of
lemA was amplified from L. monocytogenes 10403s genomic DNA with primers
that added a 5 SacI site and a 3 EcoRI site. The primer sequences used were
5-GGGGAGCTCTATTTCGGTCTATACAAC-3 and 5-AGGGAATTCTAA
TTGGCGGATGTGAGTC-3. After restriction digestion, the fragment was sub-
cloned in pONT2. The resultant plasmid, pONT4, contains an in-frame deletion
of codons 2 to 16 of lemA and is referred to as the MIGWII mutation. pONT4
was cleaved with SacI and MluI to remove a 487-bp fragment of lemA (see Fig.
1C). The digested plasmid was treated with Pfu polymerase (Stratagene) to
create blunt ends and then religated to form recombinant plasmid pNR1. pNR1
contains the wild-type ribosome-binding sequence and ATG start codon fused to
remnants of the SacI binding site as well as the last 27 bp of lemA, which are no
longer in-frame, and is referred to as the lemA mutation.
Replacement of wild-type chromosomal sequences with either the MIGWII
(strain SD9-1) or lemA (strain NR1-1578) mutation was accomplished by allelic
exchange, as described previously (2). Chromosomal mutations were confirmed
by comparing the DNA sequences of fragments amplified from L. monocytogenes
10403s, L. monocytogenes SD9-1, and L. monocytogenes NR1-1578 genomic
DNA.
Mice. BALB/c/By/J mice were obtained from the Jackson Laboratory and used
at 6 to 12 weeks of age. C.B10-H2b/LilMcd/J (BALB/c congenic at the H-2b locus;
herein referred to as C.B10 mice) were originally obtained from the Jackson
Laboratory and then maintained as a colony in a specific-pathogen-free barrier
facility at Harvard Medical School. Class Ia MHC-deficient (Kb/ Db/)
C.B10 mice were described previously (5).
Cell lines and cell culture. EL-4 mouse thymoma cells, J774 mouse macro-
phage-like cells, L2 mouse fibroblasts, L929 mouse fibroblasts, and Henle 407
human epithelial cells were obtained from the American Type Culture Collec-
tion. L2 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM)
containing 10% fetal calf serum (DMEM-10); all other cells were maintained in
a medium (RP-10) consisting of RPMI 1640 supplemented with L-glutamine,
HEPES, 50 M 2-mercaptoethanol, and 10% fetal calf serum. All cells were
incubated at 37°C with 7% CO2. Antibiotics were used at the following concen-
trations: penicillin, 50 units/ml; streptomycin, 50 g/ml; and gentamicin, 25 and
50 g/ml.
Bone marrow-derived macrophages were harvested from the femurs of
BALB/c mice, cultured in DMEM supplemented with 20% fetal calf serum and
20% L929 cell supernatant, and the medium was replenished every 3 to 4 days.
The fMIGWII-specific T-cell line S172 was prepared by stimulating splenocytes
from a Listeria-immune Kb/ Db/ C.B10 mouse on irradiated (2,000 rads)
syngeneic splenocytes coated with 10 nM synthetic N-formylated MIGWII pep-
tide (fMIGWII). The T-cell line was maintained by weekly restimulation, first in
RP-10 and after 2 weeks in RP-10 supplemented with supernatant from con-
canavalin A-stimulated rat splenocytes and 50 mM -methylmannoside (CTL
medium).
Intracellular growth assay. Cells were seeded on 12-mm round coverslips and
incubated overnight in RP-10 without antibiotics to reach confluence. Bacteria
were grown to early log phase in BHI broth, washed once with PBS, and used to
infect cell monolayers. Cells were infected (on coverslips in triplicate) at a
multiplicity of infection of 0.1 (J774 and bone marrow-derived macrophages) or
2.0 (Henle 407), incubated for 1 h, and washed three times with warm PBS, and
then RP-10 containing 25 g of gentamicin sulfate per ml was added. At that
time and at each subsequent time point, the number of bacteria associated with
each coverslip was determined by placing the coverslip in sterile distilled H2O,
vortexing vigorously for 30 s, and plating dilutions on BHI agar.
Plaque assay. L2 fibroblasts were grown to confluence in six-well dishes and
infected with L. monocytogenes at various multiplicities of infection. The cells
were incubated for 1 h and then washed three times with warm PBS. Overlays
consisting of DMEM-10, 1% agarose, and gentamicin sulfate (10 g/ml) were
added, and the cells were incubated for an additional 3 days. Plaques were
visualized by the addition of neutral red overlays (1% agarose and 0.2% neutral
red in DMEM-10). Plaque size was measured by analyzing digital images of the
overlays.
Competitive index assay. Growth of the lemA mutant was compared to
growth of wild-type bacteria during both primary and secondary Listeria infec-
tions in a competitive index assay as previously described (1). Briefly, BALB/c
mice were infected intravenously with a 1:1 mixture of DP-L3903 and NR1-1578.
For primary infections, mice were given a total of 103 CFU and sacrificed 72 h
later; for secondary infections, mice were given a total of 105 CFU and sacrificed
48 h later. Spleens and livers were harvested aseptically, homogenized and
diluted in 0.2% NP-40, and plated on BHI agar. At least 100 colonies per organ
were replica plated or patched onto BHI agar containing 2 g of erythromycin
per ml. Competitive indices were calculated by dividing the total CFU of test
strain NR1-1578 (erythromycin sensitive) by the total CFU of reference strain
DP-L3903 (erythromycin resistant).
ELISPOT assay. The frequency of antigen-specific CD8 T cells in the spleens
of mice was determined by ELISPOT assay. Flat-bottomed 96-well filtration
plates (0.45-m cellulose ester membrane; Millipore) were coated with rat anti-
mouse gamma interferon (IFN-) antibody (10 g/ml; clone R4-6A2, Pharmin-
gen) and then blocked with medium containing 5% fetal calf serum. Splenocytes
(1 	 105 to 5 	 105/well) were incubated with stimulator cells (105 EL-4 cells/
well) pretreated with 1 M synthetic peptide for 1 h in CTL medium. N-
Formylated peptides fMIVIL, fMIGWII, and fMIVTLF were purchased from
Biosynthesis Inc. (Lewisville, Tex.). After 22 to 26 h of incubation, the plates
were washed with PBS–0.25% Tween 20 (PBS-T), and any remaining cells were
lysed with distilled water. After incubation with a biotinylated rat anti-mouse
IFN- antibody (XMG1.2, Pharmingen), the plates were washed with PBS-T and
incubated with streptavidin-labeled peroxidase in PBS–5% fetal calf serum for
1 h at room temperature. Plates were developed by adding 3,3-diaminobenzi-
dine tetrahydrochloride dihydrate (Bio-Rad, Melville, N.Y.) in Tris buffer plus
hydrogen peroxide for 30 min at room temperature, and spots were detected on
the membranes with the aid of a dissecting microscope. Each spot represents an
area in which a single T cell recognized its cognate antigen and was stimulated
to locally secreted IFN-. The number of antigen-specific cells was determined
by subtracting the number of spots observed for EL-4 cells alone from the
number of spots observed for peptide-coated EL-4 cells.
Cytotoxicity assay. L. monocytogenes strains were grown with aeration in BHI
broth at 37°C for 24 h. Supernatants from these cultures were collected, and 50
l was mixed with 100 l of RP-10 containing 106 EL-4 target cells. Sodium
51chromate (100 Ci) was added, and the cells were incubated for 1 h. Where
indicated, the culture supernatants were treated with 1 mg of proteinase K per
ml overnight at 55°C or filtered through a Centricon-10 filter (Amicon; 10,000
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molecular weight cutoff passivated with 1% milk buffer). Heat-killed listeriae
were prepared by incubating stationary-phase Listeria cultures at 55°C for 4 h;
loss of viable bacteria was confirmed by plating on BHI agar. Heat-killed L.
monocytogenes organisms were incubated with target cells for a total of 2 h;
51chromate was added during the final hour of incubation. Target cells were
washed three times with RPMI 1640, resuspended in RP-10, and added (104
cells/well) to 96-well plates. Serial dilutions of S172 T cells were then added in a
final volume of 200 l/well, and the plates were incubated for 4 h. Spontaneous
release was determined in wells containing target cells with no T cells. Maximum
release was determined by the addition of 1% Triton X-100. The cytotoxic
activity of the T cells was evaluated by measuring 51Cr in the supernatant with a
Wallac (Gaithersburg, Md.) 1470 Wizard gamma counter. Percent specific lysis
was calculated with the formula [(release by T cells  spontaneous release) 

(maximum release  spontaneous release)] 	 100.
Intracellular cytokine staining. Intracellular cytokine staining was performed
with the Cytofix/Cytoperm Plus (with GolgiPlug) kit according to the manufac-
turer’s instructions (Pharmingen). EL-4 cells were pretreated with culture su-
pernatants for 30 min at 37°C. S172 T cells were added at an effector-to-target
cell ratio of 5. Cells were stained with fluorescently conjugated monoclonal
antibodies (Pharmingen) specific for CD8 (clone 53-6.7) and IFN- (XMG1.2)
and analyzed with CellQuest software on a FACScan flow cytometer (Becton
Dickinson). Phycoerythrin-conjugated rat IgG1 (R3-34) was used as an isotype
control antibody. Dead cells and monocytes were excluded by forward and side
scatter gating. For each sample, 25,000 events were collected.
RESULTS
Generation of L. monocytogenes lemA and MIGWII mu-
tants. The L. monocytogenes gene lemA encodes a 30-kDa
protein of unknown function that was first identified as the
source of the immunodominant M3-binding epitope fMIGWII
(10). lemA is located immediately adjacent to a gene that has
been designated lemB; it is not yet known whether these two
genes constitute an operon (Fig. 1A).
We generated two lemA deletion mutant strains of L. mono-
cytogenes. The first mutant strain, NR1-1578, contains a chro-
mosomal deletion spanning almost the entire lemA gene and is
referred to as the lemA mutant (Fig. 1C). It was not known at
the outset whether deletion of lemA would affect the virulence
of L. monocytogenes, resulting in a strain that was unable to
establish systemic infection in mice. Since the goal of this study
was to create a mutant Listeria strain that could be used to
infect mice so that we could then assess specific T-cell re-
sponses, a second mutant in which just the fMIGWII epitope
sequence was deleted was also created. L. monocytogenes
SD9-1 lemA contains an in-frame deletion of 16 amino acids at
the N terminus of the product and is referred to as the MIG-
WII mutant (Fig. 1B). There was no difference in the ability of
either mutant strain to grow in broth culture compared to the
parental strain L. monocytogenes 10403s (data not shown).
Intracellular growth of lemA mutant L. monocytogenes is
not impaired. One of the hallmarks of L. monocytogenes patho-
genesis is the ability of the bacteria to escape from a phagocytic
vacuole into the host cell cytoplasm, where they are able to
multiply with a doubling time of approximately 1 h in vitro
(15). To determine whether the lemA gene product was re-
quired for intracellular survival or growth, we infected macro-
phages and epithelial cells with either mutant or wild-type L.
monocytogenes and determined the total number of intracellu-
lar bacteria at various times after infection. As shown in Fig. 2,
the numbers of wild-type and mutant bacteria associated with
J774 macrophages, primary bone marrow-derived macro-
phages, and Henle 407 epithelial cells 1 h postinfection were
approximately the same, suggesting that the lemA mutant
strain did not have a defect in cell entry or survival. Intracel-
lular growth of the lemA mutant occurred in a logarithmic
manner over an 8-h time period and reached peak levels that
were similar to that observed for wild-type L. monocytogenes
(Fig. 2). These data suggest that lemA is not required for
intracellular growth in macrophages or epithelial cells.
The lemA mutant competes with wild-type Listeria during
growth in spleen and liver. Although the lemA mutant was
able to survive and replicate within tissue culture cells, it was
possible that the strain would have impaired ability to cause
systemic infection after intravenous inoculation of mice. We
used a competitive index assay to determine whether the
lemA mutant had a subtle growth defect that could be ob-
FIG. 1. Physical and genetic maps of lemA mutant L. monocyto-
genes strains. (A) Open reading frames found in wild-type L. monocy-
togenes 10403s; arrows indicate direction of transcription. The N-ter-
minal amino acid sequence of LemA is shown below; the boxed region
indicates the amino acids deleted in the MIGWII mutant strain
SD9-1. (B) N-terminal amino acid sequence of L. monocytogenes
SD9-1 LemA. Underlined amino acids represent the SacI recognition
site that replaced the 16 amino acids shown above in the wild-type
sequence. (C) Physical map of the chromosomal deletion found in
lemA mutant L. monocytogenes NR1-1578.
FIG. 2. Intracellular growth of wild-type and lemA mutant liste-
riae. Cells were infected with either wild-type L. monocytogenes 10403s
(solid squares) or lemA mutant listeriae (open squares) at a multi-
plicity of infection of either 0.1 (J774 cells and bone marrow-derived
macrophages [BMM]) or 2.0 (Henle 407 cells). One hour later, the
cells were washed extensively, and medium containing gentamicin (25
g/ml) was added. Cells were lysed in sterile water at the time points
indicated, and dilutions were plated on BHI agar to determine the
total number of cell-associated bacteria per coverslip. Average values
 standard deviation are given. Representative data from one of three
separate experiments are shown.
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served only during in vivo infection of mice. As shown in Fig.
3, there was no significant difference in the growth of the
lemA mutant compared to wild-type listeriae during primary
infection of BALB/c mice (mean competitive indices of 0.9 for
spleen and 0.8 for liver).
To assess the ability of the mutant strain to replicate in
immune animals, we infected mice with 0.1 LD50 of wild-type
L. monocytogenes and then challenged those mice 3 weeks later
with 5 LD50 of a 1:1 mixture of mutant and wild-type bacteria.
On average, there was a 2.8-fold defect in the ability of the
lemA mutant to proliferate in the liver during secondary
infection (Fig. 3; competitive indices ranging from 0.1 to 0.6).
In contrast, wild-type and mutant listeriae were recovered
from the spleen in approximately equal numbers during sec-
ondary infection. These data suggest that the lemA gene prod-
uct may play a role in intracellular survival in hepatocytes
during secondary infection and that it is not required for
growth in splenocytes.
Cell-to-cell spread of the L. monocytogenes lemA mutant is
not impaired. Auberbach et al. previously showed that certain
actA mutant strains of L. monocytogenes also display a growth
defect in liver but not spleen during infection of immunized
animals (1). ActA is essential for actin-based motility in the
host cell, a phenomenon that increases the ability of Listeria to
spread to neighboring cells. To determine if LemA was re-
quired for efficient cell-to-cell spread, we tested the ability of
the lemA mutant to form plaques in a fibroblast monolayer.
L2 cells were infected with either wild-type or lemA Listeria
for 3 days, and the plaques that formed in the cell monolayers
were visualized after the addition of neutral red. As shown in
Fig. 4, there was no significant difference in the size of the
plaques formed by the two strains. The mean plaque size
formed by the lemA mutant was 93% 4% of the plaque size
formed by L. monocytogenes 10403s. Therefore, LemA does
not appear to be necessary for efficient cell-to-cell spread dur-
ing in vitro infection of mouse fibroblasts.
fMIGWII-specific T cells are activated during infection with
lemA mutant L. monocytogenes. The results described above
established that the lemA mutant was fully capable of causing
systemic infection in either naïve or immune animals. We
therefore proceeded to ask whether protective immunity could
be established in mice immunized with lemA mutant Listeria.
To verify that the fMIGWII-specific T-cell response was abol-
ished following infection with the lemA mutants, mice were
immunized with a sublethal dose of either wild-type or mutant
L. monocytogenes. Six days later, the activation of M3-re-
stricted, Listeria-specific T cells in the spleens of these animals
was measured by IFN- ELISPOT assay. To our surprise,
fMIGWII-specific T-cell responses of only slightly reduced
magnitude were stimulated in mice immunized with either
MIGWII or lemA mutant Listeria compared to mice immu-
nized with wild-type Listeria (Fig. 5). fMIGWII-specific T cells
were below the limit of detection in uninfected mice (data not
shown). As expected, the fMIVIL- and fMIVTLF-specific T-
cell responses were unaffected following immunization with
MIGWII listeriae, suggesting that the infection proceeded as
normal and that only the LemA antigen was altered in the
mutant Listeria strain (Fig. 5A). These results suggested that L.
monocytogenes expresses a second antigen that can cross-react
with fMIGWII-specific T-cell receptors.
fMIGWII-specific T cells recognize an antigen found in the
culture supernatant of lemA Listeria. Previous reports have
shown that simple treatment of cells with either heat-killed
listeriae or supernatant from Listeria cultures results in M3-
restricted recognition by fMIGWII-specific T cells (8, 10, 13).
To determine whether the antigen that cross-reacts with
fMIGWII was similarly present in Listeria culture supernatants
or heat-killed preparations of Listeria, we generated an
fMIGWII-specific CD8 T-cell line that could be used to rec-
FIG. 3. Competitive index assay analysis of primary and secondary
infection with wild-type and lemA mutant L. monocytogenes. Groups
of four to six naïve and Listeria-immune mice were infected with a 1:1
mixture of DP-L3903 (wild type) and NR1-1578 (lemA). Mice were
sacrificed 3 days after primary infections (0.1 LD50 of total bacteria) or
2 days after secondary infections (0.1 LD50 of wild-type listeriae fol-
lowed by 5 LD50 of total bacteria 3 weeks later). Spleens and livers
were harvested and homogenized, and dilutions were plated on BHI
agar with or without erythromycin. A competitive index of 1.0 indicates
that the two strains were recovered in equal numbers. Data compiled
from three separate experiments are shown; bars indicate average
values for each experimental group. , P  0.01 as determined by a
two-sided Mann-Whitney test.
FIG. 4. Cell-to-cell spread of lemA mutant and wild-type L.
monocytogenes. Monolayers of L2 fibroblasts in six-well dishes were
infected with approximately 2.0 	 105 lemA (A) or wild-type (B) L.
monocytogenes for 3 days. Plaques were visualized by the addition of
0.2% neutral red. Representative data from one of three separate
experiments are shown.
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ognize both fMIGWII and the cross-reactive antigen in chro-
mium release assays.
Splenocytes harvested from a class Ia MHC-deficient mouse
infected 2 weeks earlier with L. monocytogenes were stimulated
in vitro with irradiated, syngeneic splenocytes coated with 10
nM fMIGWII peptide as a source of antigen. A CD8
fMIGWII-specific T-cell line (line S172) cultured from this
mouse specifically lysed J774 macrophage cells treated with
heat-killed wild-type listeriae (Fig. 6A). Specific lysis of cells
treated with heat-killed lemA listeriae was also observed,
although the level of recognition of these target cells was
significantly lower. Similar results were obtained when EL-4
thymoma cells were treated with supernatants from wild-type
and lemA Listeria cultures (Fig. 6B), suggesting that process-
ing in macrophages is not required for presentation of the
cross-reactive antigen.
We confirmed this observation by looking at the ability of
line S172 T cells to secrete IFN- in response to EL-4 cells
pretreated with Listeria culture supernatants. As shown in Fig.
6C, fMIGWII-specific T cells recognized EL-4 cells treated
with either wild-type or lemA Listeria culture supernatant.
Again, the response to the lemA supernatant was significantly
lower than that to the wild-type supernatant. Taken together,
these results suggest that small amounts of the cross-reactive
FIG. 5. Infection of mice with lemA mutant strains of L. monocytogenes results in the activation of fMIGWII-specific T cells. (A) Groups of
C.B10 mice (two to four) were given intravenous injections of 103 CFU of either 10403s (wild-type listeriae) or SD9-1 (MIGWII listeriae). Six
days later, the mice were sacrificed, and the number of fMIVIL-, fMIGWII-, and fMIVTLF-specific T cells present in the spleen of each mouse
was determined by IFN- ELISPOT assay. The average number of IFN--secreting cells per 5 	 105 splenocytes  standard deviation is shown.
Data compiled from three separate experiments are shown. (B) Groups of four C.B10 mice were infected with 103 CFU of either 10403s or
NR1-1578 (lemA). Six days later, the mice were sacrificed, and the number of fMIGWII-specific T cells present in the spleen each mouse was
determined by IFN- ELISPOT assay.
FIG. 6. lemA Listeria culture supernatants and heat-killed bacteria target cells for recognition by fMIGWII-specific T cells. Cells were treated
with wild-type (wt) or mutant (lemA) L. monocytogenes (Lm) preparations and then used as targets for lysis by fMIGWII-specific T cells (line
S172) in a standard 51Cr release assay. (A) J774 cells were treated with heat-killed (HK) L. monocytogenes for 2 h. (B) EL-4 cells were incubated
for 1 h with supernatants from L. monocytogenes cultures. The E:T (effector-to-target cell) ratio indicates the number of T cells added for every
target cell in the assay. (C) EL-4 cells were treated for 30 min with supernatants from L. monocytogenes cultures and then added to S172 T cells.
The percentage of line S172 cells that were CD8 and secreting IFN- was determined by intracellular cytokine staining. Representative data from
one of three separate experiments are shown.
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antigen are secreted or released from L. monocytogenes in a
manner similar to that of the fMIGWII epitope in LemA.
The fMIGWII cross-reactive antigen is a small protease-
resistant molecule. To further characterize the nature of the
fMIGWII cross-reactive antigen, we treated both wild-type and
lemA mutant Listeria culture supernatants with proteinase K
and used these preparations to target EL-4 cells for recogni-
tion by line S172 T cells. A significant portion of the targeting
activity found in the wild-type culture supernatant was lost
after proteinase K digestion (Fig. 7). However, the residual
antigen found in protease-digested wild-type culture superna-
tant resulted in approximately the same level of specific lysis as
observed for the untreated lemA culture supernatant. In con-
trast, proteinase K digestion of the lemA mutant supernatant
resulted in greater recognition by fMIGWII-specific T cells.
The cross-reactive antigen was not lost when undigested
lemA culture supernatant was filtered through a 10,000-mo-
lecular-weight-cutoff filter, suggesting that it is a small mole-
cule. These results indicate that a small protease-resistant an-
tigen is released from both wild-type and lemA mutant
Listeria during growth in BHI broth and that this antigen
cross-reacts with fMIGWII-specific T cells.
DISCUSSION
lemA does not appear to be an essential gene in L. mono-
cytogenes. Strain NR1-1578, which has a large chromosomal
deletion encompassing almost all of the lemA gene, did not
show a significant growth defect either in vitro or in vivo during
primary Listeria infection. The slight defect in the ability of the
lemA mutant to grow in the livers of mice during secondary
infection may suggest that LemA plays a role in intracellular
survival in hepatocytes or in avoiding the enhanced recall im-
mune response that occurs during secondary challenge. How-
ever, since this virulence defect was small, any essential func-
tion that LemA serves during infection of mice must be at least
partially compensated for by another L. monocytogenes gene
product.
The most striking finding in this report is that removing the
fMIGWII epitope embedded within LemA does not abolish
the fMIGWII-specific T-cell response that occurs during Lis-
teria infection. This suggests that there is at least one cross-
reactive antigen present in L. monocytogenes that can activate
fMIGWII-specific T cells. We provide evidence here that this
cross-reactive antigen is a small, protease-resistant molecule
that may be actively secreted by L. monocytogenes. Further
work will be required to determine whether this antigen is a
short hydrophobic N-formylated peptide with sequence simi-
larity to fMIGWII or whether this cross-reactive molecule rep-
resents a new class of antigens that can be presented by M3
molecules.
The peptide-binding grooves of MHC molecules are re-
markably conserved, with only a few polymorphic residues
involved in determining which peptides will bind with high
affinity. Analysis of the crystal structure of M3 revealed that an
N-formyl group promotes strong binding to the second posi-
tion of the groove, with room for only six more residues, most
of which point towards the backbone of the groove (24). Thus,
structural constraints would make it seem likely that the cross-
reactive antigen is a closely related hydrophobic peptide sim-
ilar in sequence to fMIGWII. However, antigen-presenting
molecules in the CD1 family have been shown to present lipids
to T cells, providing a precedent for class Ib MHC-restricted
presentation of nonpeptide antigens. Whether the L. monocy-
togenes cross-reactive antigen described here is a peptide or
nonpeptide moiety, it is also possible that it binds to a distant
site on the M3 molecule, outside of the peptide-binding
groove.
Nataraj et al. previously described a protease-resistant par-
ticulate antigen thought to be a phospholipid that purified with
heat-killed Listeria-associated antigen (HAA) (12). It was later
thought that HAA was in fact LemA because T-cell clones that
recognized HAA also recognized synthetic fMIGWII peptide
at concentrations of less than 1 nM (7). Our results are con-
sistent with their data and suggest that fMIGWII-specific T
cells can cross-react with both the 6-mer peptide fMIGWII and
the protease-resistant molecule described both here and in the
previous work.
Nataraj et al. have shown that the hydrophobic amino ter-
minus of lemA is protease resistant in vitro, so it is possible that
the hydrophobic nature of the cross-reactive antigen prevents
access by proteinase K, either due to association with a bacte-
rial lipid or due to the secondary structure of the protein (12).
However, there are two important differences between our
studies. First, in the previous studies the authors used T cells
stimulated on heat-killed Listeria to identify the HAA. We
used an fMIGWII-specific T-cell line that was stimulated in
vitro on syngeneic splenocytes coated with synthetic fMIGWII
peptide. A T-cell line stimulated on peptide should be greatly
enriched for T cells that recognize the specific peptide epitope,
unlike T cells stimulated on the heterogenous mixture of an-
tigens found in a heat-killed bacterial preparation. Second, we
were readily able to detect the fMIGWII cross-reactive antigen
in Listeria culture supernatants, while Nataraj et al. found that
HAA was predominately found in bacterial cell wall and mem-
brane preparations.
It is interesting that proteinase K treatment of the lemA
culture supernatant resulted in increased recognition by T cells
and specific release of chromium when applied to target cells.
This finding suggests that the cross-reactive antigen can be
taken up more readily by cells when a protease-sensitive por-
FIG. 7. T cells that recognize fMIGWII also recognize a small
protease-resistant molecule present in L. monocytogenes culture super-
natant. EL-4 cells were treated with 50 l of 10403s (wild-type L.
monocytogenes [wt Lm]) or NR1-1578 (lemA L. monocytogenes
[lemA Lm]) culture supernatant preparations either untreated, di-
gested with proteinase K (protK), or filtered through a 10,000-molec-
ular-weight-cutoff filter and then used as targets for recognition by
fMIGWII-specific T cells (line S172) in a 51Cr release assay. The
effector-to-target cell ratio used was 30:1. Average values  standard
deviation from one of two separate experiments are shown.
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tion of it is digested away. In fact, we did see better presenta-
tion of the lemA culture supernatant antigen on professional
antigen-presenting cells such as primary bone marrow-derived
macrophages compared to EL-4 cells (S. E. F. D’Orazio and
M. N. Starnbach, unpublished observations). This suggests that
the processing requirements for the cross-reactive antigen may
be different than for LemA and that uptake by a phagocytic cell
facilitates antigen processing. It has been shown that presen-
tation of epitopes by M3 molecules is blocked by inhibitors of
endosomal acidification and by brefeldin A, which blocks Golgi
transport (3). Presumably antigen is taken up in endosomes or
phagosomes and some proteolysis occurs within these vesicles,
resulting in peptides available to bind M3. There appear to be
both TAP-dependent and -independent pathways for presen-
tation of exogenous antigen on M3 molecules (3, 10, 11), so it
is not clear whether the antigens bind in the endoplasmic
reticulum or in a post-Golgi compartment.
If the cross-reactive antigen is a short hydrophobic pep-
tide(s) with sequence homology to fMIGWII, the availability
of the complete L. monocytogenes genome sequence should aid
in the identification of the antigen. In fact, a search of the L.
monocytogenes genome database has revealed several candi-
date genes that may serve as fMIGWII cross-reactive antigens,
and we are currently working to examine the relevance of each
of these gene products. However, although there are a seem-
ingly large number of potential M3-binding peptides to be
found within any bacterial species, it is difficult to predict M3
epitopes by simply analyzing primary amino acid sequence
data. Cytosolic formylases are very efficient at removing the
N-terminal formyl group from bacterial proteins, so it is essen-
tial to understand the topology of a candidate antigen to know
whether the formylated methionine is likely to be retained on
an amino-terminal peptide. Defining all of the types of L.
monocytogenes antigens that can stimulate CD8 T cells will
ultimately lead to a better understanding of how intracellular
bacterial pathogens are recognized and eliminated by the im-
mune system.
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